From rabbit virus to cancer vaccine?

John Gibb
Otago Daily Times

05/05/2010

A powerful new vaccine therapy for colorectal cancer is likely to emerge from “highly promising” University of Otago research, which is moving closer to human clinical trials.

This smart form of therapy uses harmless viral shells derived from rabbit haemorrhagic disease virus to deliver immunising tumour proteins.

The same approach could also be applied to a wide range of human cancers, researchers say.

This is one of several cutting-edge Otago research projects involving sciences, medical sciences and humanities which will be outlined to parliamentarians, senior ministry officials and scientists in a briefing at Parliament this evening.

The projects are being led by members of the O-Zone group of award-winning young Otago University scholars.

Read the rest of the article.

About the author

VT

Jeffry John Aufderheide is the father of a child injured as a result of vaccination. As editor of the website www.vactruth.com he promotes well-educated pediatricians, informed consent, and full disclosure and accountability of adverse reactions to vaccines.